SLCO4A1 and gastric adenocarcinoma: The analysis of the starBase database showed that the expression of SLCO4A1-AS1 in stomach adenocarcinoma (STAD) patients (n = 375) was higher than that of normal samples (n = 32) (P=1.2e − 7, Figure 1(a)).